These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7128661)

  • 1. Titration of nadolol in the treatment of hypertension.
    Papadoyannis DE; Papazachos GA; Karatzas NB
    Eur J Clin Pharmacol; 1982; 22(6):487-9. PubMed ID: 7128661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Field study: long-term antihypertensive therapy with the beta blocker nadolol in a once-a-day dosage - an outpatient study of Swiss medical practices].
    Bertel O; Conen D; Renggli I
    Schweiz Rundsch Med Prax; 1983 Feb; 72(8):264-8. PubMed ID: 6132374
    [No Abstract]   [Full Text] [Related]  

  • 3. Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol.
    Mancia G; Ferrari A; Pomidossi G; Parati G; Bertinieri G; Grassi G; Gregorini L; di Rienzo M; Zanchetti A
    Am Heart J; 1984 Oct; 108(4 Pt 2):1078-83. PubMed ID: 6148866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of essential hypertension. A comparison between nadolol, once daily, and propranolol, four times daily.
    Frithz G
    Practitioner; 1982 Mar; 226(1365):562-4. PubMed ID: 7045847
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension.
    Am J Cardiol; 1983 Dec; 52(10):1230-7. PubMed ID: 6359851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nadolol beta-blockade on blood pressure in hypertension.
    Duchin KL; Vukovich RA; Dennick LG; Groel JT; Willard DA
    Clin Pharmacol Ther; 1980 Jan; 27(1):57-63. PubMed ID: 6101312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is low-dose hydrochlorothiazide effective?
    Magee PF; Freis ED
    Hypertension; 1986 Jun; 8(6 Pt 2):II135-9. PubMed ID: 3013766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of essential hypertension with Nadolol and Hydrochlorothiazide: a two-year follow-up.
    El-Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1982; 10(2):87-91. PubMed ID: 6802691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advantages and benefits of once-daily nadolol treatment in hypertension.
    González D
    J Int Med Res; 1982; 10(5):351-6. PubMed ID: 6754507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiprolol in systemic hypertension.
    Frishman WH; Flamenbaum W; Schoenberger J; Schwartz GL; Vidt DG; Neri GS; Greenberg S; Lazar E; Godfrey JC; Stevenson A
    Am J Cardiol; 1989 Apr; 63(12):839-42. PubMed ID: 2522723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antihypertensive effects of doxazosin: a clinical overview.
    Cox DA; Leader JP; Milson JA; Singleton W
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):83S-90S. PubMed ID: 2939872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isometric exercise before and after nadolol treatment in uncomplicated essential hypertension.
    Corea L; Bentivoglio M; Provvidenza M
    Int J Clin Pharmacol Res; 1984; 4(1):35-40. PubMed ID: 6469432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study.
    Danesh BJ; Brunton J; Sumner DJ
    Clin Sci (Lond); 1984 Aug; 67(2):243-8. PubMed ID: 6146425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
    El Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1980; 8(3):193-8. PubMed ID: 6104614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension.
    Frithz G
    Curr Med Res Opin; 1978; 5(5):383-7. PubMed ID: 26519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nadolol in combination with indapamide and xipamide in resistant hypertensives.
    Dean S; Kendall MJ; Potter S; Thompson MH; Jackson DA
    Eur J Clin Pharmacol; 1985; 28(1):29-33. PubMed ID: 3987783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minoxidil, nadolol, and a diuretic. Once-a-day therapy for resistant hypertension.
    Spitalewitz S; Porush JG; Reiser IW
    Arch Intern Med; 1986 May; 146(5):882-6. PubMed ID: 3963979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
    Pupita F; Ansuini R; Belogi M; Pupita G; Gaggi S
    Int J Clin Pharmacol Res; 1985; 5(6):439-45. PubMed ID: 2869001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life quality in patients under hypotensive treatment.
    Pupita F; Ansuini R; Belogi M; Campolucci G; Gaggi S; Pupita G
    Int J Clin Pharmacol Res; 1987; 7(1):13-7. PubMed ID: 3294614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol.
    Mancia G; Ferrari A; Pomidossi G; Parati G; Bertinieri G; Grassi G; Gregorini L; Zanchetti A
    Hypertension; 1983; 5(4):573-8. PubMed ID: 6134670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.